145 related articles for article (PubMed ID: 37646068)
1. CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration.
Najafi S; Rahimi Z; Mansoori B; Mohammadi A; Mohammadnejad F; Amini M; Mokhtazadeh A; Asadzadeh Z; Chi-Shing Cho W; Baradaran B
Adv Pharm Bull; 2023 Jul; 13(3):551-562. PubMed ID: 37646068
[TBL] [Abstract][Full Text] [Related]
2. Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells.
Vasefifar P; Najafi S; Motafakkerazad R; Amini M; Safaei S; Najafzadeh B; Alemohammad H; Jafarlou M; Baradaran B
Exp Cell Res; 2023 Aug; 429(2):113681. PubMed ID: 37315760
[TBL] [Abstract][Full Text] [Related]
3. Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration.
Najafzadeh B; Motafakkerazad R; Najafi S; Amini M; Alemohammad H; Vasefifar P; Baradaran B
Pathol Res Pract; 2022 May; 233():153869. PubMed ID: 35398618
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil.
Khosravi N; Shahgoli VK; Amini M; Safaei S; Mokhtarzadeh A; Mansoori B; Derakhshani A; Baghbanzadeh A; Baradaran B
Eur J Pharmacol; 2021 Mar; 894():173871. PubMed ID: 33460610
[TBL] [Abstract][Full Text] [Related]
5. Improvement of 5-fluorouracil chemosensitivity in colorectal cancer cells by siRNA-mediated silencing of STAT6 oncogene.
Rahbar Farzam O; Baradaran B; Akbari B; Najafi S; Amini M; Yari A; Dabbaghipour R; Pourabdollah Kaleybar V; Ahdi Khosroshahi S
Iran J Basic Med Sci; 2024; 27(4):475-484. PubMed ID: 38419894
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer.
Liu J; Zhang Q; Wang J; Wang C; Lan T; Wang T; Wang B
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762705
[TBL] [Abstract][Full Text] [Related]
7. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
8. MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2.
Liu J; Huang Y; Wang H; Wu D
Int J Clin Exp Pathol; 2018; 11(12):5622-5634. PubMed ID: 31949649
[TBL] [Abstract][Full Text] [Related]
9. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
Li C; Lu K; Yang C; Du W; Liang Z
J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis.
Wang S; Cao J; Pei L
Histol Histopathol; 2023 Jan; 38(1):99-112. PubMed ID: 35900059
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.
Rashidi G; Rezaeepoor M; Mohammadi C; Solgi G; Najafi R
Mol Biol Rep; 2020 Sep; 47(9):7017-7027. PubMed ID: 32888127
[TBL] [Abstract][Full Text] [Related]
12. Demethylzeylasteral Exerts Antitumor Effects
Liu G; Lai D; Jiang Y; Yang H; Zhao H; Zhang Y; Liu D; Pang Y
Anticancer Agents Med Chem; 2022; 22(5):851-863. PubMed ID: 34102996
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon Cancer Cells by Inhibiting STAT3.
Yu Z; Chan S; Wang X; Sun R; Wang M; Wang Z; Zuo X; Chen J; Zhang H; Chen W
Drug Des Devel Ther; 2023; 17():993-1006. PubMed ID: 37020802
[TBL] [Abstract][Full Text] [Related]
14. Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU
Gao X; Zheng X; Zhang Y; Dong L; Sun L; Zhao N; Ding C; Ma Z; Wang Y
Front Cell Dev Biol; 2021; 9():788331. PubMed ID: 35071232
[No Abstract] [Full Text] [Related]
15. DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer.
Wu G; Xu X; Wan D; Zhou D; Feng Y; Chen J; Peng Z; Fang D; Shi X; Yao H; Chen G; Sun L; Yao Y; Zhou G; Yang Y; He S
Ann Transl Med; 2021 Aug; 9(16):1317. PubMed ID: 34532454
[TBL] [Abstract][Full Text] [Related]
16. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
Roshani Asl E; Rasmi Y; Baradaran B
J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
[TBL] [Abstract][Full Text] [Related]
18. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1.
Zhao J; Shi X; Dong C; Liu R; Su L; Cao C
Folia Histochem Cytobiol; 2022; 60(1):55-65. PubMed ID: 35103981
[TBL] [Abstract][Full Text] [Related]
19. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
Qin Y; Chen X; Liu Z; Tian X; Huo Z
Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
[TBL] [Abstract][Full Text] [Related]
20. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
